Hospital de Sant Pau recently hosted the First National Meeting of the GEICEN Group (Stable Research Group in Gynecologic Cancer), a gathering that brought together researchers and specialists from across Spain dedicated to the study of gynecologic cancer from a basic, translational, and clinical perspective. GEICEN is made up of 10 research groups from different academic and hospital institutions, and its objective is to promote collaborative projects that advance the understanding of these tumors and the clinical management of patients.
The event featured the participation of the Gynecological and Breast Pathology Group of the Sant Pau Research Institute (IR Sant Pau), which served as host of this first edition. Dr. Silvia Cabrera, head of the group, highlighted that “this meeting is an essential step toward consolidating a national research network in gynecologic cancer. Sharing results, challenges, and methodologies allows us to move forward faster and offer more efficient responses to patients, and for our group, hosting this first meeting is an honor and a boost to continue growing in this field.”
The program included short presentations from each of the groups that make up GEICEN, with participation from IR Sant Pau, IRYCIS, IRBLleida, IDIBELL, UB, IDIS, FMDA, and VHIR, among others. The presentations made it possible to share strategic projects and research lines in areas such as biomarkers, preclinical models, emerging therapies, biobanks, omics technologies, and new diagnostic approaches in gynecologic oncology. Representing IR Sant Pau, in addition to Dr. Silvia Cabrera, Dr. Alba Farrés also participated, presenting a new project being launched on endometrial cancer.
Following the morning scientific sessions, the event continued with internal meetings focused on the strategy of principal investigators and the coordination of early-career researchers, aimed at defining new collaborative lines and preparing future competitive proposals. The holding of this first national meeting marks an important step for GEICEN, which aims to become a stable reference space for coordinated research on gynecologic tumors, which affect thousands of women every year.
